课题基金 / 基金详情

IRF-1通过调控circ_0029589的m6A修饰促进巨噬细胞焦亡在动脉粥样硬化中的机制研究

批准号:
82000426
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
郭敏
依托单位:
学科分类:
动脉粥样硬化与动脉硬化
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
郭敏

项目摘要

结项摘要

项目成果

相似基金

相关文献

中文摘要
课题组前期研究证实,干扰素调节因子-1(IRF-1)促进急性冠脉综合征(ACS)患者巨噬细胞焦亡并在动脉粥样硬化(AS)中发挥重要作用,但调控机制有待阐明。预实验发现ACS患者单核细胞来源的巨噬细胞中hsa_circ_0029589表达显著降低,而其m6A水平及甲基化转移酶METTL3表达明显升高;IRF-1可显著抑制ACS患者巨噬细胞hsa_circ_0029589的表达并上调其m6A水平;沉默METTL3后,hsa_circ_0029589表达恢复,而巨噬细胞焦亡明显减轻。因此我们提出:IRF-1在AS中可通过调控circ_0029589的m6A修饰促进巨噬细胞焦亡。本研究拟通过在体及体外实验观察:1)AS中IRF-1的表达规律及其与circ_0029589表达、巨噬细胞焦亡的关系;2)IRF-1通过调控circ_0029589的m6A修饰促进巨噬细胞焦亡在AS的作用及机制。
英文摘要
We found that Interferon regulatory factor-1 (IRF-1) could promote macrophage pyroptosis in patients with acute coronary syndrome (ACS), which play an important role in atherosclerosis (AS); however, the regulatory mechanism remains unknown. Our preliminary experiment revealed that the relative expression of hsa_circ_0029589 was decreased, whereas the N6-methyladenosine (m6A) level of hsa_circ_0029589 and the expression of m6A methyltransferase METTL3 were significantly elevated in macrophages in patients with ACS; IRF-1 suppressed hsa_circ_0029589 expression but upregulated its m6A level; additionally, inhibition of METTL3 increased the expression of hsa_circ_0029589 and attenuated macrophage pyroptosis. Therefore, we propose that IRF-1 promote macrophage pyroptosis in atherosclerosis by modulating m6A modification of circ_0029589. We will dynamically investigate: 1) the expression of IRF-1 and its relationship with the expression of circ_0029589, macrophage pyroptosis and inflammation in AS; 2) the role and mechanism of IRF-1 promoting macrophage pyroptosis in atherosclerosis by modulating m6A modification of circ_0029589.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI: 10.3389/fcvm.2022.1060542
发表时间: 2022
期刊: Frontiers in cardiovascular medicine
影响因子: 3.6
作者: []
通讯作者:
DOI: 10.3389/fcvm.2022.872961
发表时间: 2022
期刊: Frontiers in cardiovascular medicine
影响因子: 3.6
作者: []
通讯作者:
DOI: --
发表时间: 2023
期刊: 中国比较医学杂志
影响因子:
作者: [张昕怡, 郭敏, 高慧, 刘宇]
通讯作者: 刘宇
DOI: 10.1155/2022/8569188
发表时间: 2022
期刊: CARDIOVASCULAR THERAPEUTICS
影响因子: 3.1
作者: [Pang, Naidong, Gao, Jia, Zhang, Binghang, Guo, Min, Zhang, Nan, Sun, Meng, Wang, Rui]
通讯作者: Wang, Rui
共 11 条
    国内基金
    海外基金